(PDF) P2.04-29 Preliminary Results With Tislelizumab in

P2.04-29 Preliminary Results With Tislelizumab in Chinese Patients With Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.1253

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

HER2 Mutations in Chinese Patients With Non-Small Cell Lung Cancer

English

P2.04-28 Use of Immune Checkpoint Inhibitors (ICIs) in Patients With Refractory Non-Small Cell Lung Cancer (NSCLC) and Poor Performance Status (PS)

Journal of Thoracic Oncology

Respiratory Medicine

English

Prevalence of ROS1 Fusion in Chinese Patients With Non-Small Cell Lung Cancer

Thoracic Cancer

Respiratory Medicine

English

Predictive Factors Associated With Prolonged Survival in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated With Gefitinib

British Journal of Cancer

Cancer Research

English

P2.15-29 Eligibility for Anti-Angiogenic Treatments in Patients With Squamous Non-Small Cell Lung Cancer (SQ-NSCLC): EPISQUAMAB Study (GFPC 2015-01)

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.03-02 Analysis of SMAD4 Aberrations in Chinese Patients With Non-Small-Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.04-29 Second or Third Line Nivolumab Versus First Line Nivolumab in Patients With Previously Treated Advanced Non Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

Respiratory Medicine

English

P20 Molecular Characterization of Non–Small Cell Lung Cancer (NSCLC) Patients by Next Generation Sequencing: Preliminary Data

Journal of Thoracic Oncology

Respiratory Medicine

English

Ifosfamide in Patients With Recurrent Non Small Cell Lung Cancer

Journal of Cancer Research and Clinical Oncology

Cancer Research

English